Reuters logo
BRIEF-Innate Immunotherapeutics receives FDA clearance for IND application
June 20, 2017 / 11:41 PM / in 4 months

BRIEF-Innate Immunotherapeutics receives FDA clearance for IND application

June 21 (Reuters) - Innate Immunotherapeutics Ltd:

* Received clearance from U.S. FDA for company’s investigational new drug (IND) application lodged last month Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below